108 related articles for article (PubMed ID: 8094450)
1. Calcium antagonism and structure-affinity relationships of terfenadine, a histamine H1 antagonist, and some related compounds.
Zhang MQ; Caldirola P; Timmerman H
J Pharm Pharmacol; 1993 Jan; 45(1):63-6. PubMed ID: 8094450
[TBL] [Abstract][Full Text] [Related]
2. Chiral manipulation of drug selectivity: studies on a series of terfenadine-derived dual antagonists on H1-receptors and calcium channels.
Zhang MQ; Caldirola P; Timmerman H
Agents Actions; 1994 Jun; 41 Spec No():C140-2. PubMed ID: 7976802
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of 3H-nitrendipine binding in rat aortic and cerebral cortex membranes by the new dihydropyridine calcium antagonist benidipine hydrochloride.
Ishii A
Arzneimittelforschung; 1989 Dec; 39(12):1546-50. PubMed ID: 2624603
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo characterization of a calcium modulator of the diphenylalkylamine type with selective coronary dilatory properties.
Caldirola P; Monteil A; Zandberg P; Mannhold R; Timmerman H
Arzneimittelforschung; 1997 Nov; 47(11):1211-8. PubMed ID: 9428976
[TBL] [Abstract][Full Text] [Related]
5. Comparative potencies of calcium channel antagonists and antischizophrenic drugs on central and peripheral calcium channel binding sites.
Quirion R; Lafaille F; Nair NP
J Pharm Pharmacol; 1985 Jun; 37(6):437-40. PubMed ID: 2410588
[TBL] [Abstract][Full Text] [Related]
6. The binding of [3H]nitrendipine to receptors for calcium channel antagonists in the heart, cerebral cortex, and ileum of rats.
Ehlert FJ; Roeske WR; Itoga E; Yamamura HI
Life Sci; 1982 Jun; 30(25):2191-202. PubMed ID: 7109844
[TBL] [Abstract][Full Text] [Related]
7. Allosteric modulation of [3H]nitrendipine binding to cardiac and cerebral cortex membranes by amiodarone.
Nokin P; Clinet M; Swillens S; Delisée C; Meysmans L; Chatelain P
J Cardiovasc Pharmacol; 1986; 8(5):1051-7. PubMed ID: 2429079
[TBL] [Abstract][Full Text] [Related]
8. Binding characteristics of a new 1,5-benzothiazepine, clentiazem, to rat cerebral cortex and skeletal muscle membranes.
Suzuki T; Kurosawa H; Naito K; Otsuka M; Ohashi M; Takaiti O
Eur J Pharmacol; 1991 Mar; 194(2-3):195-200. PubMed ID: 2060600
[TBL] [Abstract][Full Text] [Related]
9. Effects of KB-2796, a new calcium antagonist, and other diphenylpiperazines on [3H]nitrendipine binding.
Iwamoto T; Morita T; Kanazawa T; Ohtaka H; Ito K
Jpn J Pharmacol; 1988 Oct; 48(2):241-7. PubMed ID: 2850381
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of vascular relaxation by thaligrisine: functional and binding assays.
Tur R; Magraner J; Catret M; Elorriaga M; Ivorra MD; D'Ocon P; Bermejo A; Cabedo N; Cortes D; Anselmi E
Life Sci; 2000 Aug; 67(13):1535-48. PubMed ID: 10983849
[TBL] [Abstract][Full Text] [Related]
11. Relationship between occupation of cerebral H1-receptors and sedative properties of antihistamines. Assessment in the case of terfenadine.
Rose C; Quach TT; Llorens C; Schwartz JC
Arzneimittelforschung; 1982; 32(9a):1171-3. PubMed ID: 6129863
[TBL] [Abstract][Full Text] [Related]
12. Tissue response selectivity of calcium antagonists is not due to heterogeneity of [3H]-nitrendipine binding sites.
Bristow MR; Ginsburg R; Laser JA; McAuley BJ; Minobe W
Br J Pharmacol; 1984 Jun; 82(2):309-20. PubMed ID: 6329392
[TBL] [Abstract][Full Text] [Related]
13. [3H]diltiazem binding to calcium channel antagonists recognition sites in rat cerebral cortex.
Schoemaker H; Langer SZ
Eur J Pharmacol; 1985 May; 111(2):273-7. PubMed ID: 2410283
[TBL] [Abstract][Full Text] [Related]
14. Effects of Ca++ on [3H]diltiazem binding and its allosteric interaction with dihydropyridine calcium channel binding sites in the rat cortex.
Schoemaker H; Langer SZ
J Pharmacol Exp Ther; 1989 Feb; 248(2):710-5. PubMed ID: 2537412
[TBL] [Abstract][Full Text] [Related]
15. Histamine and growth: interaction of antiestrogen binding site ligands with a novel histamine site that may be associated with calcium channels.
Brandes LJ; Bogdanovic RP; Cawker MD; LaBella FS
Cancer Res; 1987 Aug; 47(15):4025-31. PubMed ID: 2886214
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel calcium antagonist binding site in rat brain by SR 33557.
Kenny BA; Fraser S; Spedding M
Br J Pharmacol; 1993 Jan; 108(1):93-9. PubMed ID: 7679034
[TBL] [Abstract][Full Text] [Related]
17. Certain calcium antagonists are potent displacers of [3H]phencyclidine (PCP) binding in rat brain.
Quirion R; Pert CB
Eur J Pharmacol; 1982 Sep; 83(1-2):155-6. PubMed ID: 7128698
[No Abstract] [Full Text] [Related]
18. A unitary mechanism of calcium antagonist drug action.
Murphy KM; Gould RJ; Largent BL; Snyder SH
Proc Natl Acad Sci U S A; 1983 Feb; 80(3):860-4. PubMed ID: 6572372
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the receptor selectivity of the H3 receptor antagonists, iodophenpropit and thioperamide: an interaction with the 5-HT3 receptor revealed.
Leurs R; Tulp MT; Menge WM; Adolfs MJ; Zuiderveld OP; Timmerman H
Br J Pharmacol; 1995 Oct; 116(4):2315-21. PubMed ID: 8564266
[TBL] [Abstract][Full Text] [Related]
20. Interference of sodium with [3H]-nitrendipine binding to cardiac membranes.
Schwartz J; Velly J
Br J Pharmacol; 1985 Feb; 84(2):511-5. PubMed ID: 3156649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
